Eisaku Nakamura
Directeur/Bestuurslid bij KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD.
Actieve functies van Eisaku Nakamura
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Directeur/Bestuurslid | 01-03-2016 | - |
| Independent Dir/Board Member | 01-03-2016 | - | |
| D. WESTERN THERAPEUTICS INSTITUTE, INC. | Directeur/Bestuurslid | 29-03-2018 | - |
| Independent Dir/Board Member | 29-03-2018 | - | |
| KOINOBORI Associate, Inc. | Comptroller/Controller/Auditor | 01-01-2017 | - |
| Directeur/Bestuurslid | 01-09-2013 | 01-01-2017 |
Loopbaan van Eisaku Nakamura
Eerdere bekende functies van Eisaku Nakamura
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ACUCELA INC | Directeur/Bestuurslid | 01-05-2015 | - |
Statistieken
Internationaal
| Japan | 4 |
| Verenigde Staten | 2 |
Operationeel
| Director/Board Member | 4 |
| Independent Dir/Board Member | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectoraal
| Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| D. WESTERN THERAPEUTICS INSTITUTE, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
| KOINOBORI Associate, Inc. |
- Beurs
- Insiders
- Eisaku Nakamura
- Ervaring
